Literature DB >> 9215712

FGF-2 induces nerve growth factor expression in cultured rat hippocampal neurons.

L Ferhat1, A Represa, D Zouaoui-Aggoun, W Ferhat, Y Ben-Ari, M Khrestchatisky.   

Abstract

Basic fibroblast growth factor (FGF-2) is expressed in the hippocampus and has been demonstrated to promote neurotrophic effects on hippocampal neurons in vitro. We show that these neurons, even at the embryonic stage, express the mRNAs encoding the FGF receptors, bek and flg. We have characterized the effects of FGF-2 on the expression of nerve growth factor (NGF) using the reverse transcription-coupled polymerase chain reaction, in situ hybridization and immunocytochemistry. In hippocampal neurons grown in the absence of serum, FGF-2 exposure induces an important elevation of NGF mRNA expression followed by a marked increase in NGF immunoreactivity. Combining in situ hybridization with an NGF probe and microtubule-associated protein-2 (MAP2) immunocytochemistry we show that the induction of NGF mRNA by FGF-2 is localized in MAP2-immunoreactive neurons. These results suggest roles for FGF-2 in the development of hippocampal neurons and in the maintenance of connections in the central nervous system, particularly the septo-hippocampal pathway, via the regulation of an important neurotrophin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215712     DOI: 10.1111/j.1460-9568.1997.tb01483.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

1.  Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: evidence for developmental, immediate early gene, and lesion response.

Authors:  S Rivera; E Tremblay; S Timsit; O Canals; Y Ben-Ari; M Khrestchatisky
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Inactivation of fibroblast growth factor receptor signaling in myelinating glial cells results in significant loss of adult spiral ganglion neurons accompanied by age-related hearing impairment.

Authors:  S J Wang; M Furusho; C D'Sa; S Kuwada; L Conti; D K Morest; R Bansal
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

3.  Disruption of fibroblast growth factor receptor signaling in nonmyelinating Schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity.

Authors:  Miki Furusho; Jeffrey L Dupree; Melissa Bryant; Rashmi Bansal
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

4.  Expression of the mitotic motor protein Eg5 in postmitotic neurons: implications for neuronal development.

Authors:  L Ferhat; C Cook; M Chauviere; M Harper; M Kress; G E Lyons; P W Baas
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

5.  Fasciculation and guidance of spinal motor axons in the absence of FGFR2 signaling.

Authors:  Rosa-Eva Huettl; Teresa Haehl; Andrea B Huber
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

6.  Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain.

Authors:  Ling Jin; Yosuke Nonaka; Shin Miyakawa; Masatoshi Fujiwara; Yoshikazu Nakamura
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

Review 7.  Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.

Authors:  Yoshikazu Nakamura
Journal:  Cells       Date:  2021-06-28       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.